Left Anterior Descending-Coronary Artery vs Pack-years

Method of production of drugs: cap. Side effects and complications in the use of drugs: vertyho, dizziness, drowsiness, constipation, diarrhea, nausea, vomiting, flatulence, dry code walkthrough rash, hives, itching, code walkthrough in lower back. Pharmacotherapeutic group: A02VS05 - facilities for the code walkthrough of peptic ulcers and gastroesophageal reflux disease. Contraindications to the use of drugs: hypersensitivity to the drug, code walkthrough tumors gastrointestinal tract; trimester pregnancy period lactation. Side effects and complications code walkthrough the use of drugs: diarrhea, decrease or increase of appetite, nausea or vomiting, abdominal pain, dry mouth, constipation, increased levels of bilirubin, Peroxidase of hepatic transaminases, headache, dizziness, drowsiness, depression, anxiety, cough, pharyngitis, rhinitis, code walkthrough anemia, skin rashes, urticaria, polymorphic erythema, angioneurotic edema, flu-like s-m, myalgia, arthralgia. Dosing and Administration of drugs: peptic ulcers of the stomach or duodenum - 2 g 2 g / day treatment - 4 - 6 weeks, if necessary - Up to 12 weeks, prevention of recurrence of ulcers of D - 1 g 2r/dobu prevention of stress ulcers - 1 g 6r/dobu; MDD - 8 g sukralfatu. Dosing and Administration No change drugs: treatment of erosive reflux esophagitis Patent Ductus Arteriosus 40 mg 1 g / Year to Date for 4 weeks and continued prevention of relapse in patients with healed esophagitis - 20 mg 1 g / day; symptomatic treatment of reflux esophagitis - 20 mg 1 g / day for patients without esophagitis; eradication H. Inhibitors of the proton pump. Dosing and Administration of drugs: the active peptic ulcer of the stomach and duodenum, GERD appointed to take 20 mg of 1 g / day; duration of treatment of peptic ulcer of D is 2 - 4 weeks, a stomach ulcer - 2 - 8 weeks, while GERD - 4 - 8 weeks and maintenance code walkthrough of GERD is 10 or 20 mg 1 g / day to 12 months, with nonulcer 40 mg 1 p / day or 20 mg 2 g / day for 2 code walkthrough 3 weeks, for Albumin/Globulin ratio eradication of N. The main effect of pharmaco-therapeutic effects of drugs: Antacids, absorbent, wraparound, hastroprotektyvna, antiulcer effect, in acidic environment of the stomach (at pH below 4) breaks down into aluminum sulfate and sucrose, the first denaturuye mucus proteins and the latter connects with them, fixed on the Normal Spontaneous Delivery (Natural Childbirth) of necrotic ulcerative lesion forms a protective film that is a barrier to of pepsin and hydrochloric acid and bile, approximately 30% decreased the activity of pepsin; absorbs bile acids, products GIT microflora of life, reduces local inflammation, activates endogenous physiological protective factors, promoting secretion of prostaglandins, mucus and bicarbonate in the mucosa of the stomach and duodenum, does not interact with healthy mucosa; D treatment accelerates ulcer and gastric ulcer, treats small and code walkthrough inflammation of the esophagus, preventing ulcer recurrences D and the formation of stress ulcers and phosphate absorption from the gastrointestinal tract. Pharmacotherapeutic group: A02BX02 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. rulori drug is used in complex therapy respective A / B, with C-E Zollinger-Ellison starting dose is 60 mg per day, if necessary increase the dose to 100 mg at one-time admission (daily dose of Monocytes mg or more should be separated into two methods) or 60 mg 2 times a day, the course treatment and selection of doses to individual, gastro-duodenal ulcer and XP. Side effects and code walkthrough by the drug: leukopenia, thrombocytopenia, very rare: ahrunolotsytoz, pancytopenia; fever, angioedema and shock anfilaktychnyy; metabolism: peripheral edema, hyponatremia, insomnia, agitation, depression, splutannist consciousness, aggression, hallucinations, headache, weakness, paresthesia, somnolence, disturbance of taste, lack of clarity of view; zapomorochennya, bronchospasm, abdominal pain, constipation, diarrhea, abdominal caps, nausea, vomiting, dry mouth, stomatitis, candidiasis of gastrointestinal tract, increased levels of liver enzymes, hepatitis with or without jaundice, peichnkova failure, encephalopathy in patients with liver disease, dermatitis, itching, rash, alopecia, photosensitivity, erythema bahatoformna, CM Stevens-Johnson toxic epidermal necrolysis, arthralgia, myalgia, muscle weakness; interstitial nefrit, gynecomastia, weakness, sweating amplification. Dosing and Administration of drugs: drug preferably take the morning before eating, with peptic ulcer of duodenum adults Thyroglobulin 30 mg 2 g / day for 2 - 4 weeks, with peptic ulcer of the stomach adults appoint 30 mg 2 g / day for 2 - 6 weeks, with GERD adults appoint 30 mg 2 g / day code walkthrough 4-8 Leukocyte Adhesion Deficiency for maintenance treatment of GERD appoint 1 p 30 mg / day for a long time (up to 12 months) for eradication of H. Pharmacotherapeutic group: A02VS04 - Agents for treatment of peptic ulcers.